+91 7986995600
seclislabs@gmail.com
Contact Us
Antimicrobials: Antibiotics, Antivirals, AntiProtozoals, Antiparasitics

FAMEFIX™ CV

Cefixime 200mg + Clavulanic Acid 31.25mg

Dosage Form Dry Syrup
Packing 30ML
MRP Max DPCO
Prescribed By ENT Specialist, Pulmonologist, Gynecologist, General Physician, Internal Medicine

Quick Facts

Form Dry Syrup (powder for reconstitution)
Pack 30ML
Storage Store powder below 30°C; refrigerate suspension after reconstitution and use within 7 days
Schedule H (Prescription required)
Food Effect Take with meals for optimal clavulanate tolerability
Prescribed By ENT Specialist, Pulmonologist, Gynecologist, General Physician

Key Benefits

01
Third-generation cephalosporin + beta-lactamase inhibitor — extends cefixime's gram-negative spectrum to resistant, enzyme-producing organisms
02
Oral suspension format — suitable for children and patients unable to swallow solid dosage forms
03
Dry powder presentation — protects the moisture-sensitive clavulanate component during storage
04
Completes the FAMEFIX™ range — the CV combination is available as both a tablet and a suspension within one brand

Mechanism of Action

Cefixime is a third-generation oral cephalosporin that binds penicillin-binding proteins and halts bacterial cell-wall synthesis, giving broad gram-negative cover. Clavulanic acid contributes no meaningful antibacterial activity of its own; it irreversibly inhibits bacterial beta-lactamase enzymes, protecting cefixime from enzymatic degradation.

In the dry-syrup presentation, both components are supplied as a powder for reconstitution with water. This protects the moisture-sensitive clavulanate during storage while delivering a palatable oral suspension once reconstituted — the practical route for children and for adults unable to swallow tablets.

Indications

FAMEFIX™ CV Dry Syrup is indicated where beta-lactamase-producing organisms are suspected and an oral suspension is required.

ENT Infections: Recurrent or severe acute otitis media, complicated sinusitis and tonsillitis unresponsive to standard cephalosporins.

Respiratory Tract Infections: Community-acquired pneumonia, acute exacerbations of bronchitis and pharyngitis caused by beta-lactamase-producing pathogens.

Urinary Tract Infections: Uncomplicated and complicated UTI where resistant gram-negative organisms are suspected.

Patients Unable to Swallow Tablets: Paediatric patients and adults requiring liquid dosing.

Dosage & Administration

Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.

Why FAMEFIX™ CV?

Beta-lactamase production is now widespread among common community pathogens, and plain cefixime increasingly fails against these organisms. Prescribers treating children — or any patient who cannot manage tablets — have historically had to choose between an appropriate spectrum and an appropriate dosage form.

FAMEFIX™ CV Dry Syrup closes that gap, pairing the CV combination with a paediatric-friendly suspension and giving the FAMEFIX™ range full coverage from drops through suspensions to dispersible and film-coated tablets.

Interested in franchising FAMEFIX™ CV?

Get exclusive monopoly rights in your territory. WHO-GMP certified. Pan India coverage with dedicated support.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.

Scroll to Top